Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Huszar

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Immunology|April 1, 1994
Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgML D Taylor, C E Carmack, D Huszar, et al.
Molecular and Cellular Biology|January 11, 2000
Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutationH Stubdal, C A Lynch, A Moriarty, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100R V Farese, M M Véniant, C M Cham, et al.
Cancer Chemotherapy and Pharmacology|June 4, 2011
A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumorsJ R Infante, R Kurzrock, J Spratlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterolM L Varban, F Rinninger, N Wang, et al.
Nature Genetics|February 2, 2000
A role for smad6 in development and homeostasis of the cardiovascular systemK M Galvin, M J Donovan, C A Lynch, et al.
Cell|January 10, 1997
Targeted disruption of the melanocortin-4 receptor results in obesity in miceD Huszar, C A Lynch, V Fairchild-Huntress, et al.
Investigational New Drugs|April 16, 2011
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemiaH M Kantarjian, S Padmanabhan, W Stock, et al.
Nature|March 23, 1999
The mahogany protein is a receptor involved in suppression of obesityD L Nagle, S H McGrail, J Vitale, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Immunology|April 1, 1994
Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgML D Taylor, C E Carmack, D Huszar, et al.
Molecular and Cellular Biology|January 11, 2000
Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutationH Stubdal, C A Lynch, A Moriarty, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100R V Farese, M M Véniant, C M Cham, et al.
Cancer Chemotherapy and Pharmacology|June 4, 2011
A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumorsJ R Infante, R Kurzrock, J Spratlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterolM L Varban, F Rinninger, N Wang, et al.
Nature Genetics|February 2, 2000
A role for smad6 in development and homeostasis of the cardiovascular systemK M Galvin, M J Donovan, C A Lynch, et al.
Cell|January 10, 1997
Targeted disruption of the melanocortin-4 receptor results in obesity in miceD Huszar, C A Lynch, V Fairchild-Huntress, et al.
Investigational New Drugs|April 16, 2011
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemiaH M Kantarjian, S Padmanabhan, W Stock, et al.
Nature|March 23, 1999
The mahogany protein is a receptor involved in suppression of obesityD L Nagle, S H McGrail, J Vitale, et al.
Pageof 4